Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

Presentation TCT 2025

TCT 900: Comparison of Drug-Coated Balloons and The Bioadaptor in Treatment of De Novo Coronary Lesions: A 2-Year Nationwide Analysis from SWEDEHEART

Presenter: David Erlinge

October 28, 2025

Presentation TCT 2025

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

Presenter: David Erlinge

October 27, 2025

Presentation TCT 2025

INFINITY-SWEDEHEART-RCT 1 Year Clinical Outcomes

Presenter: David Erlinge

October 26, 2025

Presentation ESC 2025

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Presenter: Robin Hofmann

August 31, 2025

Presentation TCT 2024

Overview of Latest Clinical Evidence

Presenter: David Erlinge

October 30, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

Presenter: David Erlinge

October 28, 2024

Presentation TCT 2024

TCT 290: Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the SWEDEHEART Registry

Presenter: Elmir Omerovic

October 28, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

Presenter: David Erlinge

October 28, 2024

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

Presentation THT 2024

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Presenter: Elmir Omerovic

March 05, 2024

Presentation TCT 2023

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

Presenter: Matthias Götberg

October 25, 2023

Presentation TCT 2021

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Presenter: Matthias Götberg

November 04, 2021

Presentation TCT 2019

Resting Indices vs. Hyperemic Evaluation of Physiology in ACS: What Did We Learn From DEFINE-FLAIR and Swedeheart?

Presenter: Christopher Cook

September 27, 2019

Presentation TCT 2019

2-Year Outcome Data From DEFINE-FLAIR and Swedeheart: A Critical Appraisal

Presenter: Matthias Götberg

September 27, 2019

Presentation iTOP 2019

La era de la fisiología coronaria de los índices de reposo: El corregistro de iFR como valor diferenciador a la hora de tratar la descendente anterior

Presenter: Oriol Rodriguez Leor

June 04, 2019

Presentation TCT 2018

TAKOTSUBO (SWEDEHEART): Effects of Pharmacological Interventions on Mortality in Patients With Takotsubo Syndrome

Presenter: John A. Bittl, Bernard J. Gersh, Elmir Omerovic

September 24, 2018

Presentation TCT 2018

iFR-SWEDEHEART: Two-Year Follow-up From a Randomized Trial of Instantaneous Wave-Free Ratio vs Fractional Flow Reserve Guided PCI

Presenter: Nick Curzen, Nils Johnson, Ole Fröbert

September 22, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

Presenter: Allen Jeremias

May 06, 2018

Presentation TCT 2017

DEFINE FLAIR/SWEDEHEART: Critique and Unanswered Questions

Presenter: David J. Cohen, Ajay J. Kirtane, Habib Samady

November 01, 2017

Presentation TCT 2017

DEFINE FLAIR/SWEDEHEART: Topline Findings and Practice Implications

Presenter: David J. Cohen, Ajay J. Kirtane, Thomas Engstroem

November 01, 2017

Advertisement

TCT 900: Comparison of Drug-Coated Balloons and The Bioadaptor in Treatment of De Novo Coronary Lesions: A 2-Year Nationwide Analysis from SWEDEHEART

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

INFINITY-SWEDEHEART-RCT 1 Year Clinical Outcomes

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Overview of Latest Clinical Evidence

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

TCT 290: Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the SWEDEHEART Registry

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Resting Indices vs. Hyperemic Evaluation of Physiology in ACS: What Did We Learn From DEFINE-FLAIR and Swedeheart?

2-Year Outcome Data From DEFINE-FLAIR and Swedeheart: A Critical Appraisal

La era de la fisiología coronaria de los índices de reposo: El corregistro de iFR como valor diferenciador a la hora de tratar la descendente anterior

TAKOTSUBO (SWEDEHEART): Effects of Pharmacological Interventions on Mortality in Patients With Takotsubo Syndrome

iFR-SWEDEHEART: Two-Year Follow-up From a Randomized Trial of Instantaneous Wave-Free Ratio vs Fractional Flow Reserve Guided PCI

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

DEFINE FLAIR/SWEDEHEART: Critique and Unanswered Questions

DEFINE FLAIR/SWEDEHEART: Topline Findings and Practice Implications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content